FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Evangelista Dyr

Research Profile

Chemicals & Drugs

Anatomy

Blood Platelets

Procedures

Disorders

Afibrinogenemia

Physiology

Living Beings

Cattle

Co-author Network

Publications

TOP 3
Tomáš Riedel; Zuzana Riedelová-Reicheltová; César Rodriguez-Emmenegger; Jan Evangelista Dyr; Milan Houska; Pavel Májek; Eduard Brynda
Complete identification of proteins responsible for human blood plasma fouling on poly(ethylene glycol)-based surfaces.
Pavel Májek; Klára Pečánková; Zuzana Riedelová-Reicheltová; Jirí Suttnar; Jaroslav Cermák; Jan Evangelista Dyr
Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome.
Zuzana Reicheltová; Tomáš Riedel; Jirí Suttnar; Pavel Májek; Jan Evangelista Dyr
Simplified platelet sample preparation for SDS-PAGE-based proteomic studies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Evangelista Dyr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tomáš Riedel; Zuzana Riedelová-Reicheltová; César Rodriguez-Emmenegger; Jan Evangelista Dyr; Milan Houska; Pavel Májek; Eduard Brynda
Complete identification of proteins responsible for human blood plasma fouling on poly(ethylene glycol)-based surfaces.
Langmuir : the ACS journal of surfaces and colloids 2013;29(10):3388-97.
2013: Pavel Májek; Klára Pečánková; Zuzana Riedelová-Reicheltová; Jirí Suttnar; Jaroslav Cermák; Jan Evangelista Dyr
Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome.
Proteome science 2013;11(1):14.
2012: Zuzana Reicheltová; Tomáš Riedel; Jirí Suttnar; Pavel Májek; Jan Evangelista Dyr
Simplified platelet sample preparation for SDS-PAGE-based proteomic studies.
Proteomics. Clinical applications 2012;6(7-8):374-81.
2012: Martin A Maly; Milan Oravec; Zuzana Reicheltova; Jirí Suttnar; Josef Veselka; Roman Kotlin; Pavel Majek; Jan Evangelista Dyr
Proteomic analysis of plasma samples from acute coronary syndrome patients - the pilot study.
International journal of cardiology 2012;157(1):126-8.
2012: Roman Kotlín; Jirí Suttnar; Marie Urbánková; Irena Cápová; Ingrid Hrachovinová; Jan Evangelista Dyr
Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
American journal of hematology 2012;87(5):555-7.
2012: Pavel Májek; Zuzana Reicheltová; Jirí Suttnar; Jaroslav Cermák; Jan Evangelista Dyr
Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome.
Proteome science 2012;10(1):31.
2011: Roman Kotlín; Kateřina Zichová; Jirí Suttnar; Zuzana Reicheltová; Peter Salaj; Ingrid Hrachovinová; Jan Evangelista Dyr
Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy.
Thrombosis research 2011;127(3):277-8.
2011: Tomas Riedel; Jirí Suttnar; Eduard Brynda; Milan Houska; Leonid Medved; Jan Evangelista Dyr
Fibrinopeptides A and B release in the process of surface fibrin formation.
Blood 2011;117(5):1700-6.
2011: Pavel Májek; Zuzana Reicheltová; Jirí Suttnar; Jaroslav Cermák; Jan Evangelista Dyr
Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia.
Proteome science 2011;9():64.
2011: Pavel Májek; Martin Malý; Milan Oravec; Klára Pečánková; Zuzana Reicheltová; Jirí Suttnar; Jan Evangelista Dyr
Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1.
Journal of translational medicine 2011;9():84.
2010: Roman Kotlín; Zuzana Reicheltová; Jirí Suttnar; Peter Salaj; Ingrid Hrachovinová; Tomás Riedel; Martin Malý; Milan Oravec; Jan Kvasnicka; Jan Evangelista Dyr
Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.
Journal of thrombosis and thrombolysis 2010;30(3):311-8.
2010: Pavel Májek; Zuzana Reicheltová; Jana Stikarová; Jirí Suttnar; Alžběta Sobotková; Jan Evangelista Dyr
Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin.
Proteome science 2010;8():56.
2009: Alzbeta Sobotková; Leona Másová-Chrastinová; Jirí Suttnar; Jana Stikarová; Pavel Májek; Zuzana Reicheltová; Roman Kotlín; John W Weisel; Martin Malý; Jan Evangelista Dyr
Antioxidants change platelet responses to various stimulating events.
Free radical biology & medicine 2009;47(12):1707-14.
2009: Roman Kotlín; Zuzana Reicheltová; Martin Malý; Jirí Suttnar; Alzbeta Sobotková; Peter Salaj; Jana Hirmerová; Tomás Riedel; Jan Evangelista Dyr
Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
Thrombosis and haemostasis 2009;102(3):479-86.
2009: Elena Filová; Eduard Brynda; Tomás Riedel; Lucie Bacáková; Jaroslav Chlupác; Vera Lisá; Milan Houska; Jan Evangelista Dyr
Vascular endothelial cells on two-and three-dimensional fibrin assemblies for biomaterial coatings.
Journal of biomedical materials research. Part A 2009;90(1):55-69.
2008: Roman Kotlín; Zuzana Reicheltová; Alzbeta Sobotková; Jirí Suttnar; Peter Salaj; Dagmar Pospísilová; Petr Smejkal; Leona Chrastinová; Jan Evangelista Dyr
Three cases of abnormal fibrinogens: sumperk (Bbeta His67Leu), Unicov (Bbeta Gly414Ser), and Brno (gammaArg275His).
Thrombosis and haemostasis 2008;100(6):1199-200.
2008: Milan Houska; Eduard Brynda; Andrey Solovyev; Adéla Broucková; Petra Krízová; Martina Vanícková; Jan Evangelista Dyr
Hemocompatible albumin-heparin coatings prepared by the layer-by-layer technique. The effect of layer ordering on thrombin inhibition and platelet adhesion.
Journal of biomedical materials research. Part A 2008;86(3):769-78.
2008: Roman Kotlín; Alzbeta Sobotková; Jirí Suttnar; Peter Salaj; Lenka Walterová; Tomás Riedel; Zuzana Reicheltová; Jan Evangelista Dyr
A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
European journal of haematology 2008;81(2):123-9.
2008: Roman Kotlín; Alzbeta Sobotková; Tomás Riedel; Peter Salaj; Jirí Suttnar; Zuzana Reicheltová; Pavel Májek; Tarek Khaznadar; Jan Evangelista Dyr
Acquired dysfibrinogenemia secondary to multiple myeloma.
Acta haematologica 2008;120(2):75-81.
2007: Petra Krízová; Leona Másová; Jirí Suttnar; Peter Salaj; Jan Evangelista Dyr; Jirí Homola; M Pecka
The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose.
Journal of biomedical materials research. Part A 2007;82(2):274-80.
2007: Roman Kotlín; Martina Chytilová; Jirí Suttnar; Peter Salaj; Tomás Riedel; Jirí Santrůcek; Pavel Klener; Jan Evangelista Dyr
A novel fibrinogen variant--Praha I: hypofibrinogenemia associated with gamma Gly351Ser substitution.
European journal of haematology 2007;78(5):410-6.
2007: Roman Kotlín; Martina Chytilová; Jirí Suttnar; Tomás Riedel; Peter Salaj; Jan Blatný; Jirí Santrůcek; Pavel Klener; Jan Evangelista Dyr
Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
Thrombosis research 2007;121(1):75-84.
2006: Martina Vanícková; Jirí Suttnar; Jan Evangelista Dyr
The adhesion of blood platelets on fibrinogen surface: comparison of two biochemical microplate assays.
Platelets 2006;17(7):470-6.
2006: Jirí Suttnar; E Otáhalová; J Cermák; Jan Evangelista Dyr
Effects of malondialdehyde content in low density lipoproteins on platelet adhesion.
Platelets 2006;17(2):92-9.
2006: Ingrid Hrachovinová; S Rittich; Peter Salaj; Jirí Suttnar; Jan Evangelista Dyr; T Suláková; J Pták; P Dulícek; T Seeman
[Hereditary form of thrombotic thrombocytopenic purpura].
Casopís lékar̆ů c̆eských 2006;145(5):390-2.
2003: Leona Másová; Jitka Rysavá; Petra Krízová; Jirí Suttnar; Peter Salaj; Jan Evangelista Dyr; Jirí Homola; Jakub Dostálek; K Myska; M Pecka
Hemostyptic effect of oxidized cellulose on blood platelets.
Sborník lékar̆ský 2003;104(2):231-6.
2003: Petra Krízová; Jitka Rysavá; M Vanícková; Petr Cieslar; Jan Evangelista Dyr
Image analysis of blood platelets adhesion.
Sborník lékar̆ský 2003;104(2):223-9.
2002: Jitka Rysavá; Leona Másová; Jan Evangelista Dyr; Jirí Suttnar; Peter Salaj; Jakub Dostálek; K Myska; M Pecka
[Effect of oxidized cellulose on fibrin formation and blood platelets].
Casopís lékar̆ů c̆eských 2002;141 Suppl():50-3.
2002: Jirí Suttnar; Leona Másová; T Scheiner; V Sorelová; Jan Evangelista Dyr
[Role of free radicals in blood platelet activation].
Casopís lékar̆ů c̆eských 2002;141 Suppl():47-9.
2001: Jirí Suttnar; Leona Másová; Jan Evangelista Dyr
Influence of citrate and EDTA anticoagulants on plasma malondialdehyde concentrations estimated by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 2001;751(1):193-7.
2000: Eduard Brynda; Milan Houska; M Jirousková; Jan Evangelista Dyr
Albumin and heparin multilayer coatings for blood-contacting medical devices.
Journal of biomedical materials research 2000;51(2):249-57.
2000: Jirí Suttnar; Jan Evangelista Dyr; L Dolecková
Determination of the putative binding sites for thrombin receptor activating peptide through a hydropathic complementary approach.
Thrombosis and haemostasis 2000;83(1):165-70.
1997: M Jirousková; Jan Evangelista Dyr; Jirí Suttnar; Karel Holada; B Trnková
Platelet adhesion to fibrinogen, fibrin monomer, and fibrin protofibrils in flowing blood -- the effect of fibrinogen immobilization and fibrin formation.
Thrombosis and haemostasis 1997;78(3):1125-31.
1997: H Fortová; Jirí Suttnar; Jan Evangelista Dyr; J Pristach
Simultaneous isolation of protein C activator, fibrin clot promoting enzyme (fibrozyme) and phospholipase A2 from the venom of the southern copperhead snake.
Journal of chromatography. B, Biomedical sciences and applications 1997;694(1):49-53.
1997: Jirí Suttnar; J Cermák; Jan Evangelista Dyr
Solid-phase extraction in malondialdehyde analysis.
Analytical biochemistry 1997;249(1):20-3.
1997: Petr Cieslar; Karel Holada; Jan Evangelista Dyr; K Smetana; O Matousková; Ivan Spicka
[The Bernard-Soulier syndrome. A hereditary functional and structural disorder of blood platelets].
Casopís lékar̆ů c̆eských 1997;136(7):210-4.
1997: M Jirousková; Jirina Bartunková; Karel Smetana; J Lukás; Jirí Vacík; Jan Evangelista Dyr
Comparative study of human monocyte and platelet adhesion to hydrogels in vitro - effect of polymer structure.
Journal of materials science. Materials in medicine 1997;8(1):19-23.
1996: F Marecek; Jan Evangelista Dyr; Hana Cajthamlová
Comparison of several mouse and rat monoclonal antibodies against human fibrinogen.
Hybridoma 1996;15(6):423-7.
1995: Karel Holada; Jan Evangelista Dyr; K Koubek; Jirí Suttnar; Jan Simák
Characterization of platelet antigen for CD45RA monoclonal antibodies.
Immunobiology 1995;192(3-4):272-7.
1994: Vladimir Liska; Jan Evangelista Dyr; Jirí Suttnar; I Hirsch; Vladimír Vonka
Production and simple purification of a protein encoded by part of the gag gene of HIV-1 in the Escherichia coli HB101F+ expression system inducible by lactose and isopropyl-beta-D-thiogalactopyranoside.
Journal of chromatography. B, Biomedical applications 1994;656(1):127-33.
1994: Jirí Suttnar; Jan Evangelista Dyr; Eva Hamsíková; J Novák; Vladimír Vonka
Procedure for refolding and purification of recombinant proteins from Escherichia coli inclusion bodies using a strong anion exchanger.
Journal of chromatography. B, Biomedical applications 1994;656(1):123-6.
1992: Jirí Suttnar; Jan Evangelista Dyr; H Fortová; Vladimir Liska; Vladimír Vonka
[New methods of isolating recombinant proteins].
Casopís lékar̆ů c̆eských 1992;131(24-25):756-8.
1992: Jan Evangelista Dyr; Jirí Suttnar; H Fortová; Hana Cajthamlová
[Fibrinogen seen as an independent cardiovascular factor from the molecular aspect].
Casopís lékar̆ů c̆eských 1992;131(24-25):733-6.
1991: Ivan Spicka; Petr Cieslar; Jan Evangelista Dyr; O Matousová
[Hemostasis disorders in monoclonal gammopathies].
Sborník lékar̆ský 1991;93(9-10):277-86.
1991: Jirí Suttnar; Jan Evangelista Dyr; J Pristach; Karel Holada
Versatile modular microelectrophoresis system and the simultaneous preparation of large numbers of polyacrylamide gels.
Journal of chromatography 1991;563(1):184-7.
1991: Jan Evangelista Dyr; Jirí Suttnar
Affinity high-performance liquid chromatography on heparin-Glc-Spheron.
Journal of chromatography 1991;563(1):124-8.
1991: Ivan Spicka; Petr Cieslar; Jan Evangelista Dyr; O Matousová
[Hemostasis disorders in monoclonal gammopathies].
Sborník lékar̆ský 1991;93(9-10):277-86.
1991: Karel Holada; Jan Evangelista Dyr; Jirí Suttnar; Jan Simák
Comparison of rat and human major platelet glycoproteins.
Comparative biochemistry and physiology. B, Comparative biochemistry 1991;99(2):399-403.
1990: H Fortová; Jan Evangelista Dyr; Jirí Suttnar
Isolation of a fibrinogen-converting enzyme ficozyme from the venom of Bothrops asper by one-step affinity chromatography on blue sepharose.
Journal of chromatography 1990;523():312-6.
1990: Jan Evangelista Dyr; Hana Cajthamlová; Jirí Suttnar
[Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
Casopís lékar̆ů c̆eských 1990;129(43):1349-51.
1990: Petr Cieslar; Jan Evangelista Dyr; J Suttnar; O Matousová; B Friedmann
[Glanzmann thrombasthenia--a defect in the surface membrane of platelets].
Vnitr̆ní lékar̆ství 1990;36(8):729-37.
1990: P Korínková; Karel Holada; Jan Evangelista Dyr
[Alloimmune neonatal thrombocytopenia due to anti-P1A1 thrombocyte antibodies].
Ceskoslovenská pediatrie 1990;45(7):399-401.
1990: Jan Evangelista Dyr; Jirí Suttnar; Jan Simák; H Fortová; F Kornalík
The action of a fibrin-promoting enzyme from the venom of Agkistrodon contortrix contortrix on rat fibrinogen and plasma.
Toxicon : official journal of the International Society on Toxinology 1990;28(11):1364-7.
1989: Jirí Suttnar; Jan Evangelista Dyr
Distortion of the electrophoretic titration curves of some proteins.
Electrophoresis 1989;10(10):704-8.
1989: M Vopatová; A Májský; J Suttnar; Jan Evangelista Dyr
[The effect of blood platelet freezing on their antigen activity].
Vnitr̆ní lékar̆ství 1989;35(10):982-6.
1989: Jan Evangelista Dyr; B Blombäck; B Hessel; F Kornalík
Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
Biochimica et biophysica acta 1989;990(1):18-24.
1989: Jan Evangelista Dyr; B Hessel; Jirí Suttnar; F Kornalík; B Blombäck
Fibrinopeptide-releasing enzymes in the venom from the southern copperhead snake (Agkistrodon contortrix contortrix).
Toxicon : official journal of the International Society on Toxinology 1989;27(3):359-73.
1988: Jan Evangelista Dyr; Jirí Suttnar; F Kornalík
Assessment of a complex mixture of interacting proteins in the coagulant active venom from Agkistrodon contortrix contortrix.
Folia haematologica (Leipzig, Germany : 1928) 1988;115(1-2):203-7.
1988: Jirí Suttnar; Jan Evangelista Dyr; F Kornalík
Evaluation of individual variability in the composition of Agkistrodon contortrix contortrix venom by means of HPLC and two-dimensional PAGE.
Folia haematologica (Leipzig, Germany : 1928) 1988;115(1-2):197-202.
1987: Jan Evangelista Dyr; Jirí Suttnar
On the increased retention volume of human haemoglobin in high-performance gel filtration.
Journal of chromatography 1987;408():303-7.
1987: V Slavíková; Jan Evangelista Dyr; K Motycka; K Pristoupilová; P Holý; K Slavík
Organ distribution of fibrinogen-bound methotrexate in mice with Gardner lymphosarcoma.
Neoplasma 1987;34(3):269-76.
1986: V Brabec; F Kornalík; E Syrist'ová; Jan Evangelista Dyr
[Use of cobra toxin factor in the diagnosis of paroxysmal hemoglobinuria].
Vnitr̆ní lékar̆ství 1986;32(6):569-75.
1986: B Hessel; S Stenbjerg; Jan Evangelista Dyr; B Kudryk; L Therkildsen; B Blombäck
Fibrinogen Aarhus--a new case of dysfibrinogenemia.
Thrombosis research 1986;42(1):21-37.
1986: Jan Evangelista Dyr; E Hermanová; K Slavík; Z Vodrázka
The effect of fibrinogen-methotrexate derivatives on HeLa cell growth.
Neoplasma 1986;33(4):401-7.
1985: V Brabec; F Kornalík; J Zák; Jan Evangelista Dyr
Use of some snake venoms in the diagnostics of paroxysmal nocturnal hemoglobinuria (PNH).
Folia haematologica (Leipzig, Germany : 1928) 1985;112(2):293-302.
1983: Jan Evangelista Dyr; K Slavík; Z Vodrázka
Chemical binding of folic acid and methotrexate to bovine fibrinogen.
Thrombosis research 1983;31(5):737-46.
1983: Jan Evangelista Dyr; H Fortová; Z Vodrázka; F Kornalík
Fast protein liquid chromatography of Echis carinatus venom.
Journal of chromatography 1983;261(1):163-5.
1983: H Fortová; Jan Evangelista Dyr; Z Vodrázka; F Kornalík
Fractionation of Echis carinatus venom by affinity chromatography on immobilized lectins.
Journal of chromatography 1983;260(2):522-6.
1983: Jan Evangelista Dyr; B Blombäck; F Kornalík
The action of prothrombin activated by Ecarin on fibrinogen.
Thrombosis research 1983;30(3):225-34.
1983: Jan Evangelista Dyr; B Blombäck; F Kornalík
The fibrinogenolytic and procoagulant activity of southern copperhead venom enzymes.
Thrombosis research 1983;30(3):185-94.
1983: Jan Evangelista Dyr; B Blombäck; F Kornalík
Ecarin-mediated release of fibrinopeptides in human plasma.
Thrombosis research 1983;30(2):179-82.
1983: H Fortová; Jan Evangelista Dyr; Z Vodrázka; F Kornalík
Isolation of the prothrombin-converting enzyme from fibrinogenolytic enzymes of Echis carinatus venom by chromatographic and electrophoretic methods.
Journal of chromatography 1983;259(3):473-9.
1982: K Motycka; Jan Evangelista Dyr; A Macáková; K Slavík
Effect of free and bovine fibrinogen-bound methotrexate and dibromoaminopterin on the dissemination of solid Gardner lymphosarcoma.
Neoplasma 1982;29(2):197-204.
1981: K Motycka; K Slavík; Jan Evangelista Dyr; A Balcarová; Z Vodrázka
The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
Neoplasma 1981;28(1):3-10.